Lucid (LCID) S-4/A 14 May 21 Registration of securities issued in business combination transactions (amended) Financial data

Document And Entity Information

Document And Entity Information	8 Months Ended
	Dec. 31, 2020
Document And Entity Information
Document Type	S-4/A
Amendment Flag	true
Amendment Description	Amendment No. 1
Entity Registrant Name	Churchill Capital Corp IV
Entity Central Index Key	0001811210
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false

BALANCE SHEET

BALANCE SHEET	Dec. 31, 2020USD ($)
Current Assets
Cash	$ 3,592,857
Prepaid expenses	937,786
Total Current Assets	4,530,643
Cash and marketable securities held in Trust Account	2,070,086,006
TOTAL ASSETS	2,074,616,649
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities - accrued expenses	1,446,951
Current income taxes payable	81,422
Warrant liability	142,200,500
Deferred underwriting payable	72,450,000
Total Liabilities	216,178,873
Commitments
Class A common stock subject to possible redemption 185,343,777 shares at redemption value	1,853,437,770
Stockholders' Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Additional paid-in capital	68,460,540
Accumulated deficit	(63,467,875)
Total Stockholders' Equity	5,000,006
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	2,074,616,649
Class A Common Stock
Stockholders' Equity
Common stock value	2,166
Class B Common Stock
Stockholders' Equity
Common stock value	$ 5,175

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical) - $ / shares	Dec. 31, 2020	Sep. 30, 2020	Aug. 03, 2020	Jul. 30, 2020
Temporary Equity, Shares Outstanding	185,343,777	186,248,002	191,473,711
Preferred Stock, Par or Stated Value Per Share	$ 0.0001
Preferred Stock, Shares Authorized	1,000,000
Preferred Stock, Shares Issued	0
Preferred Stock, Shares Outstanding	0
Class A Common Stock
Temporary Equity, Shares Outstanding	185,343,777			185,343,777
Common Stock, Par or Stated Value Per Share	$ 0.0001			$ 0.0001
Common Stock, Shares Authorized	400,000,000			400,000,000
Common Stock, Shares, Issued	21,656,223			21,656,223
Common Stock, Shares, Outstanding	7,436,173			7,436,173
Class B Common Stock
Common Stock, Par or Stated Value Per Share	$ 0.0001			$ 0.0001
Common Stock, Shares Authorized	100,000,000			100,000,000
Common Stock, Shares, Issued	51,750,000			51,750,000
Common Stock, Shares, Outstanding	51,750,000			51,750,000

STATEMENT OF OPERATIONS

STATEMENT OF OPERATIONS	8 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Formation and operating costs	$ 2,976,423
Loss from operations	(2,976,423)
Other income:
Interest earned on marketable securities held in Trust Account	531,361
Loss on warrant liabilities	(58,778,500)
Transaction costs attributable to the Initial Public Offering	(2,167,536)
Unrealized gain on marketable securities held in Trust Account	4,645
Other expense, net	(60,410,030)
Loss before provision for income taxes	(63,386,453)
Provision for income taxes	(81,422)
Net Loss	$ (63,467,875)
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption | shares	188,268,610
Basic and diluted net income per share, Class A common stock subject to possible redemption | $ / shares	$ 0
Basic and diluted weighted average shares outstanding, Non-redeemable common stock | shares	62,139,949
Basic and diluted net loss per share, Non-redeemable common stock | $ / shares	$ (1.02)
Class A Common Stock
Other income:
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption | shares	186,268,610
Basic and diluted net income per share, Class A common stock subject to possible redemption | $ / shares	$ 0
Non-redeemable common stock
Other income:
Basic and diluted weighted average shares outstanding, Non-redeemable common stock | shares	62,139,948
Basic and diluted net loss per share, Non-redeemable common stock | $ / shares	$ (1.02)

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Common StockClass A Common Stock	Common StockClass B Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Apr. 29, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Balance (in shares) at Apr. 29, 2020	0	0
Net loss					(54,304,650)
Balance at Sep. 30, 2020					5,000,006
Balance at Apr. 29, 2020	$ 0	$ 0	0	0	0
Balance (in shares) at Apr. 29, 2020	0	0
Issuance of Class B common stock	$ 0	$ 5,175	19,825	0	25,000
Issuance of Class B common stock (in shares)		51,750,000
Sale of 207,000,000 Units, net of underwriting discounts and offering expenses	$ 20,700	$ 0	1,921,859,951	0	1,921,880,651
Sale of 207,000,000 Units, net of underwriting discounts and offering expenses (in shares)	207,000,000
Class A common stock subject to possible redemption	$ (18,534)	0	(1,853,419,236)	0	(1,853,437,770)
Class A common stock subject to possible redemption (in shares)	(185,343,777)
Net loss	$ 0	0	0	(63,467,875)	(63,467,875)
Balance at Dec. 31, 2020	$ 2,166	$ 5,175	$ 68,460,540	$ (63,467,875)	$ 5,000,006
Balance (in shares) at Dec. 31, 2020	21,656,223	51,750,000

STATEMENT OF CHANGES IN STOCK_2

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)	8 Months Ended
	Dec. 31, 2020shares
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
Partners' Capital Account, Units, Sale of Units	207,000,000

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS	8 Months Ended
	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (63,467,875)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(531,361)
Unrealized gain on marketable securities held in Trust Account	(4,645)
Loss on warrant liabilities	58,778,500
Transaction costs attributable to Initial Public Offering	2,167,536
Changes in operating assets and liabilities:
Prepaid expenses	(937,786)
Accrued expenses	1,446,951
Income taxes payable	81,422
Net cash used in operating activities	(2,467,258)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(2,070,000,000)
Cash withdrawn from Trust Account to pay taxes	450,000
Net cash used in investing activities	(2,069,550,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discounts paid	2,033,596,400
Proceeds from sale of Private Placement Warrants	42,850,000
Proceeds from promissory note - related party	550,000
Repayment of promissory note - related party	(550,000)
Payment of offering costs	(861,285)
Net cash provided by financing activities	2,075,610,115
Net Change in Cash	3,592,857
Cash - End of period	3,592,857
Non-Cash investing and financing activities:
Initial classification of Class A common stock subject to possible redemption	1,914,737,110
Change in value of Class A common stock subject to possible redemption	(61,299,340)
Deferred underwriting fee payable	$ 72,450,000

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	8 Months Ended
	Dec. 31, 2020
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Churchill Capital Corp IV (formerly known as Annetta Acquisition Corp) (the “Company”) was incorporated in Delaware on April 30, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has one subsidiary, Air Merger Sub, Inc., a direct, wholly owned subsidiary of the Company incorporated in Delaware on February 19, 2021 (“Merger Sub”) (see Note 12). As of December 31, 2020, the Company had not commenced any operations. All activity for the period from April 30, 2020 (inception) through December 31, 2020 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), identifying a target company for a Business Combination, and activities in connection with the proposed acquisition of Atieva, Inc., d/b/a Lucid Motors, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Atieva”) (see Note 12). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statements for the Company’s Initial Public Offering were declared effective on July 29, 2020. On August 3, 2020, the Company consummated the Initial Public Offering of 207,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 27,000,000 Units, at $10.00 per Unit, generating gross proceeds of $2,070,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 42,850,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Churchill Sponsor IV LLC, (the “Sponsor”), generating gross proceeds of $42,850,000 which is described in Note 5. Transaction costs amounted to $109,714,885, consisting of $36,403,600 of underwriting fees, $72,450,000 of deferred underwriting fees and $861,285 of other offering costs. Following the closing of the Initial Public Offering on August 3, 2020, an amount of $2,070,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a‑7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account, as described below, except that interest earned on the Trust Account can be released to the Company to fund working capital requirements, subject to an annual limit of  $1,000,000 and/or to pay its tax obligations. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding taxes payable on interest income earned from the Trust Account and the deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest, net of amounts withdrawn for working capital requirements, subject to an annual limit of $1,000,000 and/or to pay its taxes (“permitted withdrawals”)). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law or stock exchange requirements and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor and its permitted transferees will agree to vote their Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its rights to liquidating distributions from the Trust Account with respect to its Founder Shares if the Company fails to consummate a Business Combination within the Combination Window (as defined below) and (c) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination by August 3, 2022 (or November 3, 2022 if the Company has an executed letter of intent, agreement in principle or definitive agreement for a Business Combination by August 3, 2022) (the “Combination Window”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (net of permitted withdrawals and up to $100,000 to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Window. The Sponsor has agreed to waive its right to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Window. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Window. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Window and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii) the amount per Public Share held in the Trust Account as of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, in each case net of permitted withdrawals. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID‑19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Liquidity The Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its shareholders prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account outside of the Trust Account for working capital purposes. As of December 31, 2020, the Company had $3,592,857 in its operating bank accounts, $2,070,086,006 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital of $3,218,168. As of December 31, 2020, approximately $86,000 of the amount on deposit in the Trust Account represented interest income, which is available to pay the Company's tax obligations. Based on the foregoing, the Company believes it will have sufficient cash to meet its needs for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. On February 22, 2021, the Company entered into a convertible promissory note with the Sponsor pursuant to which the Sponsor agreed to loan the Company up to an aggregate principal amount of $1,500,000 (see Note 12) .

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	8 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding Public Warrants (as defined in Note 4) and Private Placement Warrants (collectively, with the Public Warrants, the “Warrants”) issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the Warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender offer or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of stock, all holders of the Warrants would be entitled to receive cash for their Warrants (the “tender offer provision”). On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the Securities and Exchange Commission together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement. In further consideration of the SEC Statement, the Company’s management further evaluated the Warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company’s Private Placement Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the tender offer provision fails the “classified in stockholders’ equity” criteria as contemplated by ASC Section 815-40-25. As a result of the above, the Company should have classified the Warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the Warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. See Notes 3, 8, 9, 10 and 11. The Company’s accounting for the Warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported investments held in trust, operating expenses, or cash. The table below summarizes the effects of the restatement on the financial statements for all periods being restated: As Previously As Reported Adjustments Restated Balance sheet as of August 3, 2020 (audited) Total Liabilities $ 72,450,000 $ 83,422,000 $ 155,872,000 Class A Common Stock Subject to Possible Redemption 1,998,159,110 (83,422,000) 1,914,737,110 Class A Common Stock 718 835 1,553 Additional Paid-in Capital 4,995,112 2,166,701 7,161,813 Accumulated Deficit (1,000) (2,167,536) (2,168,536) Shareholders’ Equity 5,000,005 — 5,000,005 Number of shares subject to redemption 199,815,911 (8,342,200) 191,473,711 Balance sheet as of September 30, 2020 (unaudited) Total Liabilities $ 72,483,333 $ 135,402,500 $ 207,885,833 Class A Common Stock Subject to Possible Redemption 1,998,003,495 (135,402,500) 1,862,600,995 Class A Common Stock 721 1,354 2,075 Additional Paid-in Capital 5,150,724 54,146,682 59,297,406 Accumulated Deficit (156,614) (54,148,036) (54,304,650) Shareholders’ Equity 5,000,006 — 5,000,006 Number of shares subject to redemption 199,787,373 (13,539,371) 186,248,002 Balance sheet as of December 31, 2020 (audited) Total Liabilities $ 73,978,373 $ 142,200,500 $ 216,178,873 Class A Common Stock Subject to Possible Redemption 1,995,638,270 (142,200,500) 1,853,437,770 Class A Common Stock 744 1,422 2,166 Additional Paid-in Capital 7,515,926 60,944,614 68,460,540 Accumulated Deficit (2,521,839) (60,946,036) (63,467,875) Shareholders’ Equity 5,000,006 — 5,000,006 Number of shares subject to redemption 199,563,827 (14,220,050) 185,343,777 Statement of Operations for the three Month Ended September 30, 2020 (unaudited) Net loss $ (155,614) $ (54,148,036) $ (54,303,650) Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 199,815,911 (8,342,200) 191,473,711 Basic and diluted net income per share, Class A common stock subject to possible redemption 0.00 0.00 0.00 Basic and diluted weighted average shares outstanding, Non-redeemable common stock 53,784,534 5,259,213 59,043,747 Basic and diluted net loss per share, Non-redeemable common stock 0.00 (0.92) (0.92) Statement of Operations for the period from April 30, 2020 (inception) to September 30, 2020 (unaudited) Net loss $ (156,614) $ (54,148,036) $ (54,304,650) Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 199,815,911 (8,342,200) 191,473,711 Basic and diluted net income per share, Class A common stock subject to possible redemption 0.00 0.00 0.00 Basic and diluted weighted average shares outstanding, Non-redeemable common stock 51,169,291 3,693,493 54,862,784 Basic and diluted net loss per share, Non-redeemable common stock 0.00 (0.99) (0.99) Statement of Operations for the period from April 30, 2020 (inception) to December 31, 2020 (audited) Net loss $ (2,521,839) $ (60,946,036) $ (63,467,875) Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 199,798,408 (11,529,798) 188,268,610 Basic and diluted net income per share, Class A common stock subject to possible redemption 0.00 0.00 0.00 Basic and diluted weighted average shares outstanding, Non-redeemable common stock 54,384,479 7,755,470 62,139,949 Basic and diluted net loss per share, Non-redeemable common stock (0.05) (0.97) (1.02) Statement of Cash Flows for the period from April 30, 2020 (inception) to December 31, 2020 (audited) Net loss $ (2,521,839) $ (60,946,036) $ (63,467,875) Loss on warrant liabilities — 58,778,500 58,778,500 Transaction costs attributable to Initial Public Offering — 2,167,536 2,167,536 Initial classification of Class A common stock subject to possible redemption 1,998,159,110 (83,422,000) 1,914,737,110 Change in value of Class A common stock subject to possible redemption (2,520,840) (58,778,500) (61,299,340) Statement of Cash Flows for the period from April 30, 2020 (inception) to September 30, 2020 (unaudited) Net loss $ (156,614) $ (54,148,036) $ (54,304,650) Loss on warrant liabilities — 51,980,500 51,980,500 Transaction costs attributable to Initial Public Offering — 2,167,536 2,167,536 Initial classification of Class A common stock subject to possible redemption 1,998,159,110 (83,422,000) 1,914,737,110 Change in value of Class A common stock subject to possible redemption (155,615) (51,980,500) (52,136,115)

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	8 Months Ended
	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents consist of mutual funds. The Company did not have any cash equivalents as of December 31, 2020. Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. Through December 31, 2020, the Company withdrew $450,000 of interest earned on the Trust Account for working capital purposes. Warrant Liability The Company accounts for the Warrants in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The Public Warrants and Private Placement Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation and a modified Black Scholes model, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security “CARES” Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“NOL) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. The Company does not believe that the CARES Act will have a significant impact on Company’s financial position or statement of operations. Net Income (Loss) per Common Share Net income (loss) per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase an aggregate of 84,250,000 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of income (loss) per share for Class A common stock subject to possible redemption in a manner similar to the two-class method of income (loss) per ordinary share. Net income (loss) per common share, basic and diluted, for Class A common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Class A common stock subject to possible redemption outstanding since original issuance. Net income (loss) per share, basic and diluted, for non-redeemable ordinary shares is calculated by dividing the net loss, adjusted for income or loss on marketable securities attributable to Class A common stock subject to possible redemption, by the weighted average number of non-redeemable ordinary shares outstanding for the period. Non-redeemable common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. Non-redeemable common stock participates in the income or loss on marketable securities based on the non-redeemable shares’ proportionate interest. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from April 30, 2020 (inception) through December 31, 2020 Class A Common Stock Subject to Possible Redemption Numerator: Earnings allocable to Class A common stock subject to possible redemption Interest income $ 475,781 Unrealized gain on investments held in Trust Account 4,159 Less: Company’s portion available to be withdrawn to pay taxes (193,315) Less: Company’s portion available to be withdrawn for working capital purposes (286,625) Net income allocable to Class A common stock subject to possible redemption $ — Denominator: Weighted average Class A common stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 188,268,610 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable Common Stock Numerator: Net loss minus net earnings Net loss $ (63,467,875) Less: Net income allocable to Class A common stock subject to possible redemption — Non-redeemable net loss $ (63,467,875) Denominator: Weighted average non-redeemable Class B common stock Basic and diluted weighted average shares outstanding, Non-redeemable Class B common stock 62,139,949 Basic and diluted net loss per share, Non-redeemable Class B common stock $ (1.02) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	8 Months Ended
	Dec. 31, 2020
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 207,000,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 27,000,000 Units, at $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-fifth of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). The Units sold in the Initial Public Offering comprise an aggregate of 207,000,000 shares of Class A common stock and 41,400,000 Public Warrants.

PRIVATE PLACEMENT

PRIVATE PLACEMENT	8 Months Ended
	Dec. 31, 2020
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 42,850,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $42,850,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Window, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	8 Months Ended
	Dec. 31, 2020
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On May 22, 2020, the Sponsor purchased 21,562,500 shares of the Company’s Class B common stock for an aggregate price of $25,000 (the “Founder Shares”). On July 14, 2020, the Company effected a stock dividend of one-third of a share of Class B common stock for each outstanding share of Class B common stock, on July 27, 2020, the Company effected a stock dividend of 0.50 to 1 share of Class B common stock for each outstanding share of Class B common stock and on July 30, 2020, the Company effected a stock dividend of 0.20 to 1 share of Class B common stock for each outstanding share of Class B common stock, resulting in 51,750,000 shares of Class B common stock being issued and outstanding. All share and per-share amounts have been retroactively restated to reflect the stock dividends. The Founder Shares included an aggregate of up to 6,750,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option, 6,750,000 Founder Shares are no longer subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or similar transaction after a Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after a Business Combination, the Founder Shares will be released from the lock-up. Administrative Support Agreement The Company entered into an agreement whereby, commencing on July 30, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of the Sponsor a total of $50,000 per month for office space, administrative and support services. For the period from April 30, 2020 (inception) through December 31, 2020, the Company incurred and paid $250,000 in fees for these services. Advisory Fee The Company may engage M. Klein and Company, LLC, an affiliate of the Sponsor, or another affiliate of the Sponsor, as its lead financial advisor in connection with a Business Combination and may pay such affiliate a customary financial advisory fee in an amount that constitutes a market standard financial advisory fee for comparable transactions. Promissory Note — Related Party On May 13, 2020, the Sponsor agreed to loan the Company an aggregate of up to $600,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of December 31, 2021 or the completion of the Initial Public Offering. The borrowings outstanding under the note in the amount of $550,000 were repaid upon the consummation of the Initial Public Offering on August 3, 2020. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants.

COMMITMENTS

COMMITMENTS	8 Months Ended
	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
COMMITMENTS	NOTE 7. COMMITMENTS AND CONTINGENCIES Registration Rights Pursuant to a registration rights agreement entered into on July 29, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $72,450,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement. The underwriters waived the upfront underwriting discount on 19,982,000 Units, resulting in a reduction of the upfront underwriting discount of $3,996,400. In addition, the underwriters reimbursed the Company an aggregate of $1,000,000 for costs incurred in connection with the Initial Public Offering. Legal Fees As of December 31, 2020, the Company incurred legal fees of $2,152,960. These fees will only become due and payable upon the consummation of an initial Business Combination (see Note 12).

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	8 Months Ended
	Dec. 31, 2020
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY	NOTE 8. STOCKHOLDERS’ EQUITY Preferred Stock  — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At December 31, 2020, there were no shares of preferred stock issued or outstanding. Class A Common Stock  — On July 30, 2020, the Company amended its Amended and Restated Certificate of Incorporation such that the Company is authorized to issue 400,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At December 31, 2020, there were 21,656,223 shares of Class A common stock issued or outstanding, excluding 185,343,777 shares of Class A common stock subject to possible redemption Class B Common Stock  — On July 30, 2020, the Company amended its Amended and Restated Certificate of Incorporation such that the Company is authorized to issue 100,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. At December 31, 2020, there were 51,750,000 shares of Class B common stock issued and outstanding Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination in consideration for such seller’s interest in the Business Combination target, any private placement-equivalent warrants issued, or to be issued, to any seller in a Business Combination.

WARRANT LIABILITY

WARRANT LIABILITY	8 Months Ended
	Dec. 31, 2020
WARRANT LIABILITY
WARRANT LIABILITY	NOTE 9. WARRANT LIABILITY Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its reasonable best efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available. Once the warrants become exercisable, the Company may redeem the Public Warrants: · in whole and not in part; · at a price of $0.01 per warrant; · upon a minimum of 30 days’ prior written notice of redemption, or the 30‑day redemption period, to each warrant holder; and · if, and only if, the closing price of the Company’s Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

INCOME TAX

INCOME TAX	8 Months Ended
	Dec. 31, 2020
INCOME TAX
INCOME TAX	NOTE 10. INCOME TAX The Company’s net deferred tax asset is as follows: December 31, 2020 Deferred tax asset Startup/organizational expenses $ 596,809 Unrealized gain on marketable securities (2,900) Total deferred tax asset 593,909 Valuation Allowance (593,909) Deferred tax asset, net of allowance $ — The income tax provision consists of the following: As of December 31, 2020 Federal Current $ 81,422 Deferred (593,909) State and Local Current — Deferred — Change in valuation allowance 593,909 Income tax provision $ 81,422 As of December 31, 2020, the Company did not have any U.S. federal and state net operating loss carryovers available to offset future taxable income. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from April 30, 2020 (inception) through December 31, 2020, the change in the valuation allowance was $593,909. A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: December 31, 2020 Statutory federal income tax rate 21.0 % State taxes, net of federal tax benefit 0.0 % Loss on warrant liability (19.5) % Transaction costs incurred in connection with IPO (0.7) % Valuation allowance (0.9) % Income tax provision (0.1) % The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company’s tax returns for the year ended December 31, 2020 remain open and subject to examination. The Company considers New York to be a significant state tax jurisdiction.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	8 Months Ended
	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 11. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Level 2: Level 3: The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 2,070,086,006 Liabilities: Warrant Liability – Public Warrants 1 $ 62,928,000 Warrant Liability – Private Placement Warrants 3 $ 79,272,500 The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are measured at fair value at inception and on a recurring basis, with changes in fair value recorded in the statement of operations. At issuance, the Warrant Liability for Public Warrants and Private Placement Warrants were valued as of July 30, 2020 using a Monte Carlo simulation and a modified Black Scholes model, respectively, which are considered to be a Level 3 fair value measurements. Subsequent to the Public Warrants detachment from the Units, the Public Warrants are valued based on quoted market price, under ticker CCIV.WS, which is a Level 1 fair value. The Monte Carlo simulation’s primary unobservable input utilized in determining the fair value of the Warrants is the probability of consummation of the Business Combination. The probability assigned to the consummation of the Business Combination was 80% which was estimated based on the observed success rates of business combinations for special purpose acquisition companies. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. As of issuance and December 31, 2020, the estimated fair value of Warrant Liability — Private Placement Warrants were determined using a Black-Scholes valuation and based on the following significant inputs: At As of December 31, issuance 2020 Exercise price $ 11.50 $ 11.50 Stock price $ 9.80 $ 10.01 Volatility 19.8 % 30 % Probability of completing a Business Combination 80.0 % 80 % Term 5.33 5.33 Risk-free rate 0.34 % 0.50 % Dividend yield 0.0 % 0.0 % The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of April 30, 2020 (inception) $ — $ — $ — Initial measurement on July 30, 2020 42,850,000 40,572,000 83,422,000 Change in valuation inputs or other assumptions 36,422,500 22,356,000 58,778,500 Fair value as of December 31, 2020 $ 79,272,500 $ 62,928,000 $ 142,200,500

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	8 Months Ended
	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 12. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below and in Note 2, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. Merger Agreement On February 22, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Merger Sub and Atieva, relating to a proposed business combination transaction between the Company and Atieva. Pursuant to the Merger Agreement, Merger Sub will merge with and into Atieva with Atieva being the surviving entity in the merger (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Transactions”). The aggregate consideration to be paid to the shareholders of Atieva will be equal to (a) $11,750,000,000 plus (b) (i) all cash and cash equivalents of Atieva and its subsidiaries less (ii) all indebtedness for borrowed money of Atieva and its subsidiaries, in each case as of two business days prior to the closing date (the “Equity Value”) and will be paid entirely in shares of Class A common stock, par value $0.0001 per share, of the Company (the “Class A Common Stock”) in an amount equal to $10.00 per share (the “Merger Consideration”). At the effective time of the Merger: (i) each share of capital stock of Atieva (the “Atieva Shares”) will be cancelled and automatically deemed for all purposes to represent the right to receive, in the aggregate, the Merger Consideration. All share incentive plan or similar equity-based compensation plans maintained for employees of Atieva will be assumed by the Company and all outstanding options to purchase Atieva Shares (each, a “Atieva Option”) and each restricted stock unit award (“RSU”) with respect to Atieva Shares (each, a “Atieva RSU”) will be assumed by the Company as described below. For purposes of the following paragraph, the “Exchange Ratio” means the Equity Value per share divided by $10.00. (ii) each Atieva Option will become an option to purchase shares of Class A Common Stock (each, an “Assumed Option”), on the same terms and conditions (including applicable vesting, exercise and expiration provisions) as applied to the Atieva Option immediately prior to the effective time of the Merger, except that (i) the number of shares of Class A Common Stock subject to such Assumed Option shall equal the product of (x) the number of Atieva Shares that were subject to the option immediately prior to the effective time of the Merger, multiplied by (y) the Exchange Ratio, rounded down to the nearest whole share, and (B) the per-share exercise price shall equal the quotient of (1) the exercise price per Atieva Share at which such option was exercisable immediately prior to the effective time of the Merger, divided by (2) the Exchange Ratio, rounded up to the nearest whole cent. (iii) each Atieva RSU, will be assumed by the Company and become an RSU with respect to shares of Class A Common Stock (each, an “Assumed RSU”) on the same terms and conditions (including applicable vesting provisions) as applied to each Atieva RSU immediately prior to the effective time of the Merger, except that the number of shares of Class A Common Stock subject to such Assumed RSU Award will be equal the product of (x) the number of Atieva Shares that were subject to such RSU immediately prior to the effective time of the Merger, multiplied by (y) the Exchange Ratio, rounded down to the nearest whole share. The Merger Agreement contains customary representations, warranties and covenants by the parties thereto and the closing is subject to certain conditions as further described in the Merger Agreement. Subscription Agreement In connection with the execution of the Merger Agreement, the Company entered into certain common stock subscription agreements (the “Subscription Agreements”) with certain investment funds (the “PIPE Investors”) pursuant to which, the Company has agreed to issue and sell to the PIPE Investors $2.5 billion of Class A common stock (the “PIPE Shares”) in reliance on an exemption from registration under Section 4(a)(2) under the Securities Act at a purchase price of $15 per share (the “PIPE Investment”). Pursuant to the Subscription Agreements, the PIPE Investors have agreed to not transfer any PIPE Shares until the later of (i) the effectiveness of the registration statement to be filed following the closing of the Transactions to register the PIPE Shares and (ii) September 1, 2021. The closing of the PIPE Investment is conditioned on all conditions set forth in the Merger Agreement having been satisfied or waived and other customary closing conditions, and the Transactions will be consummated immediately following the closing of the PIPE Investment. The Subscription Agreements will terminate upon the earlier to occur of (i) the termination of the Merger Agreement and (ii) the mutual written agreement of the parties thereto. The Subscription Agreements provide that the Company is required to file with the SEC, within 30 days after the consummation of the Transactions, a shelf registration statement covering the resale of the PIPE Shares and to use its commercially reasonable efforts to have such registration statement declared effective as soon as practicable after the filing thereof but no later than the earlier of (i) the 90th day (or 150th day if the SEC notifies the Company that it will “review” such registration statement) following the closing of the PIPE Investment and (ii) the 10th business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that such registration statement will not be “reviewed” or will not be subject to further review. Consulting Agreements On February 20, 2021, the Company entered into a transactional support agreement with a service provider, pursuant to which the service provider agreed to render certain financial advisory and capital markets advisory services for a potential Business Combination. The Company agreed to pay the service provider a fee of (i) $6,000,000 is payable upon the consummation of a Business Combination (ii) $500,000 is payable upon consummation of the financing (iii) out-of-pocket expenses not to exceed $125,000 without prior approval. Promissory Note On February 22, 2021, the Company entered into a convertible promissory note with the Sponsor pursuant to which the Sponsor agreed to loan the Company up to an aggregate principal amount of $1,500,000 (the “Note”). The Note is non-interest bearing and payable on the earlier of (i) the date of which the Company consummates a Business Combination or (ii) the date that the winding up of the Company. If the Company does not consummate a Business Combination, the Company may use a portion of any funds held outside the Trust Account to repay the Promissory Note; however, no proceeds from the Trust Account may be used for such repayment. Up to $1,500,000 of the Note may be converted into warrants at a price of $1.00 per warrant at the option of the Sponsor. The warrants would be identical to the Private Placement Warrants. The Company borrowed an aggregate of $1,500,000 on February 22, 2021. Legal Proceedings On March 3, 2021, Richard Hofman, a purported stockholder of the Company, filed a complaint, individually and on behalf of other of the Company stockholders, in the Superior Court of the State of California against the Company, Lucid, and other unnamed defendants. The complaint alleged claims for fraud, negligent misrepresentation, and false advertising and unfair business practices in connection with allegedly false and misleading statements and omissions in the Company's public filings, concerning the proposed merger between the Company and Lucid. The complaint sought injunctive relief, as well as compensatory and punitive damages. On March 8, 2021, plaintiff filed an ex parte application for a temporary restraining order and preliminary injunction, which the Company opposed and the court denied on March 10, 2021. Plaintiff filed an amended complaint on March 22, 2021, solely in a personal capacity and not on behalf of any other Company stockholders. The amended complaint alleges claims for fraud against defendants Lucid and Peter Rawlinson, and negligent misrepresentation against the Company, Lucid, and Mr. Rawlinson. The amended complaint seeks compensatory and punitive damages. Plaintiff filed an amended complaint on March 22, 2021, solely in a personal capacity and not on behalf of any other Churchill stockholders. The amended complaint alleges claims for fraud against defendants Lucid and Peter Rawlinson, and negligent misrepresentation against Churchill, Lucid, and Mr. Rawlinson. The amended complaint seeks compensatory and punitive damages. On April 18, 2021, Randy Phillips, a purported stockholder of the Company, filed a complaint, individually and on behalf of other Company stockholders, in the United States District Court for the Northern District of Alabama against the Company, Atieva, Inc. (doing business as Lucid), Michael Klein, Jay Taragin, and Peter Rawlinson. The complaint alleges claims for violations of the federal securities laws under Section 10(b) and Section 20(a) of the Exchange Act in connection with allegedly false and misleading statements and omissions concerning Lucid's business plans and prospects, as well as the proposed merger between the Company and Lucid. The complaint seeks compensatory and punitive damages.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	8 Months Ended
	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents consist of mutual funds. The Company did not have any cash equivalents as of December 31, 2020.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. Through December 31, 2020, the Company withdrew $450,000 of interest earned on the Trust Account for working capital purposes.
Warrant Liability	Warrant Liability The Company accounts for the Warrants in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The Public Warrants and Private Placement Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation and a modified Black Scholes model, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security “CARES” Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“NOL) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. The Company does not believe that the CARES Act will have a significant impact on Company’s financial position or statement of operations.
Net Income (Loss) per Common Share	Net Income (Loss) per Common Share Net income (loss) per common share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Public Offering and Private Placement to purchase an aggregate of 84,250,000 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of income (loss) per share for Class A common stock subject to possible redemption in a manner similar to the two-class method of income (loss) per ordinary share. Net income (loss) per common share, basic and diluted, for Class A common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Class A common stock subject to possible redemption outstanding since original issuance. Net income (loss) per share, basic and diluted, for non-redeemable ordinary shares is calculated by dividing the net loss, adjusted for income or loss on marketable securities attributable to Class A common stock subject to possible redemption, by the weighted average number of non-redeemable ordinary shares outstanding for the period. Non-redeemable common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. Non-redeemable common stock participates in the income or loss on marketable securities based on the non-redeemable shares’ proportionate interest. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from April 30, 2020 (inception) through December 31, 2020 Class A Common Stock Subject to Possible Redemption Numerator: Earnings allocable to Class A common stock subject to possible redemption Interest income $ 475,781 Unrealized gain on investments held in Trust Account 4,159 Less: Company’s portion available to be withdrawn to pay taxes (193,315) Less: Company’s portion available to be withdrawn for working capital purposes (286,625) Net income allocable to Class A common stock subject to possible redemption $ — Denominator: Weighted average Class A common stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 188,268,610 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable Common Stock Numerator: Net loss minus net earnings Net loss $ (63,467,875) Less: Net income allocable to Class A common stock subject to possible redemption — Non-redeemable net loss $ (63,467,875) Denominator: Weighted average non-redeemable Class B common stock Basic and diluted weighted average shares outstanding, Non-redeemable Class B common stock 62,139,949 Basic and diluted net loss per share, Non-redeemable Class B common stock $ (1.02)
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	8 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Summarizes the effects of the restatement on the financial statements	The table below summarizes the effects of the restatement on the financial statements for all periods being restated: As Previously As Reported Adjustments Restated Balance sheet as of August 3, 2020 (audited) Total Liabilities $ 72,450,000 $ 83,422,000 $ 155,872,000 Class A Common Stock Subject to Possible Redemption 1,998,159,110 (83,422,000) 1,914,737,110 Class A Common Stock 718 835 1,553 Additional Paid-in Capital 4,995,112 2,166,701 7,161,813 Accumulated Deficit (1,000) (2,167,536) (2,168,536) Shareholders’ Equity 5,000,005 — 5,000,005 Number of shares subject to redemption 199,815,911 (8,342,200) 191,473,711 Balance sheet as of September 30, 2020 (unaudited) Total Liabilities $ 72,483,333 $ 135,402,500 $ 207,885,833 Class A Common Stock Subject to Possible Redemption 1,998,003,495 (135,402,500) 1,862,600,995 Class A Common Stock 721 1,354 2,075 Additional Paid-in Capital 5,150,724 54,146,682 59,297,406 Accumulated Deficit (156,614) (54,148,036) (54,304,650) Shareholders’ Equity 5,000,006 — 5,000,006 Number of shares subject to redemption 199,787,373 (13,539,371) 186,248,002 Balance sheet as of December 31, 2020 (audited) Total Liabilities $ 73,978,373 $ 142,200,500 $ 216,178,873 Class A Common Stock Subject to Possible Redemption 1,995,638,270 (142,200,500) 1,853,437,770 Class A Common Stock 744 1,422 2,166 Additional Paid-in Capital 7,515,926 60,944,614 68,460,540 Accumulated Deficit (2,521,839) (60,946,036) (63,467,875) Shareholders’ Equity 5,000,006 — 5,000,006 Number of shares subject to redemption 199,563,827 (14,220,050) 185,343,777 Statement of Operations for the three Month Ended September 30, 2020 (unaudited) Net loss $ (155,614) $ (54,148,036) $ (54,303,650) Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 199,815,911 (8,342,200) 191,473,711 Basic and diluted net income per share, Class A common stock subject to possible redemption 0.00 0.00 0.00 Basic and diluted weighted average shares outstanding, Non-redeemable common stock 53,784,534 5,259,213 59,043,747 Basic and diluted net loss per share, Non-redeemable common stock 0.00 (0.92) (0.92) Statement of Operations for the period from April 30, 2020 (inception) to September 30, 2020 (unaudited) Net loss $ (156,614) $ (54,148,036) $ (54,304,650) Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 199,815,911 (8,342,200) 191,473,711 Basic and diluted net income per share, Class A common stock subject to possible redemption 0.00 0.00 0.00 Basic and diluted weighted average shares outstanding, Non-redeemable common stock 51,169,291 3,693,493 54,862,784 Basic and diluted net loss per share, Non-redeemable common stock 0.00 (0.99) (0.99) Statement of Operations for the period from April 30, 2020 (inception) to December 31, 2020 (audited) Net loss $ (2,521,839) $ (60,946,036) $ (63,467,875) Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 199,798,408 (11,529,798) 188,268,610 Basic and diluted net income per share, Class A common stock subject to possible redemption 0.00 0.00 0.00 Basic and diluted weighted average shares outstanding, Non-redeemable common stock 54,384,479 7,755,470 62,139,949 Basic and diluted net loss per share, Non-redeemable common stock (0.05) (0.97) (1.02) Statement of Cash Flows for the period from April 30, 2020 (inception) to December 31, 2020 (audited) Net loss $ (2,521,839) $ (60,946,036) $ (63,467,875) Loss on warrant liabilities — 58,778,500 58,778,500 Transaction costs attributable to Initial Public Offering — 2,167,536 2,167,536 Initial classification of Class A common stock subject to possible redemption 1,998,159,110 (83,422,000) 1,914,737,110 Change in value of Class A common stock subject to possible redemption (2,520,840) (58,778,500) (61,299,340) Statement of Cash Flows for the period from April 30, 2020 (inception) to September 30, 2020 (unaudited) Net loss $ (156,614) $ (54,148,036) $ (54,304,650) Loss on warrant liabilities — 51,980,500 51,980,500 Transaction costs attributable to Initial Public Offering — 2,167,536 2,167,536 Initial classification of Class A common stock subject to possible redemption 1,998,159,110 (83,422,000) 1,914,737,110 Change in value of Class A common stock subject to possible redemption (155,615) (51,980,500) (52,136,115)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	8 Months Ended
	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of basic and diluted loss per common share	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from April 30, 2020 (inception) through December 31, 2020 Class A Common Stock Subject to Possible Redemption Numerator: Earnings allocable to Class A common stock subject to possible redemption Interest income $ 475,781 Unrealized gain on investments held in Trust Account 4,159 Less: Company’s portion available to be withdrawn to pay taxes (193,315) Less: Company’s portion available to be withdrawn for working capital purposes (286,625) Net income allocable to Class A common stock subject to possible redemption $ — Denominator: Weighted average Class A common stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 188,268,610 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable Common Stock Numerator: Net loss minus net earnings Net loss $ (63,467,875) Less: Net income allocable to Class A common stock subject to possible redemption — Non-redeemable net loss $ (63,467,875) Denominator: Weighted average non-redeemable Class B common stock Basic and diluted weighted average shares outstanding, Non-redeemable Class B common stock 62,139,949 Basic and diluted net loss per share, Non-redeemable Class B common stock $ (1.02)

INCOME TAX (Tables)

INCOME TAX (Tables)	8 Months Ended
	Dec. 31, 2020
INCOME TAX
Schedule of Company's net deferred tax asset	The Company’s net deferred tax asset is as follows: December 31, 2020 Deferred tax asset Startup/organizational expenses $ 596,809 Unrealized gain on marketable securities (2,900) Total deferred tax asset 593,909 Valuation Allowance (593,909) Deferred tax asset, net of allowance $ —
Schedule of components of Company's income tax provision	The income tax provision consists of the following: As of December 31, 2020 Federal Current $ 81,422 Deferred (593,909) State and Local Current — Deferred — Change in valuation allowance 593,909 Income tax provision $ 81,422
Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate	A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: December 31, 2020 Statutory federal income tax rate 21.0 % State taxes, net of federal tax benefit 0.0 % Loss on warrant liability (19.5) % Transaction costs incurred in connection with IPO (0.7) % Valuation allowance (0.9) % Income tax provision (0.1) %

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	8 Months Ended
	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
Schedule of assets and liabilities that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Marketable securities held in Trust Account 1 $ 2,070,086,006 Liabilities: Warrant Liability – Public Warrants 1 $ 62,928,000 Warrant Liability – Private Placement Warrants 3 $ 79,272,500
Schedule of significant inputs	As of issuance and December 31, 2020, the estimated fair value of Warrant Liability — Private Placement Warrants were determined using a Black-Scholes valuation and based on the following significant inputs: At As of December 31, issuance 2020 Exercise price $ 11.50 $ 11.50 Stock price $ 9.80 $ 10.01 Volatility 19.8 % 30 % Probability of completing a Business Combination 80.0 % 80 % Term 5.33 5.33 Risk-free rate 0.34 % 0.50 % Dividend yield 0.0 % 0.0 %
Schedule of changes in the fair value of warrant liabilities	The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of April 30, 2020 (inception) $ — $ — $ — Initial measurement on July 30, 2020 42,850,000 40,572,000 83,422,000 Change in valuation inputs or other assumptions 36,422,500 22,356,000 58,778,500 Fair value as of December 31, 2020 $ 79,272,500 $ 62,928,000 $ 142,200,500

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($)	Aug. 03, 2020	Dec. 31, 2020	Feb. 22, 2021
Number of subsidiaries		1
Proceeds from Issuance Initial Public Offering		$ 2,033,596,400
Class of warrant or right, exercise price of warrants or rights		$ 11.50
Proceeds from Issuance of Warrants		$ 42,850,000
Deferred Underwriting Fee Payable Non current		72,450,000
Working Capital Requirement Fund Annual Limit	$ 1,000,000
Temporary Equity, Redemption Price Per Share	$ 10
Maximum Percentage Of Shares Eligible From Redemption	15.00%
Dissolution Expenses Payable	$ 100,000
Cash		3,592,857
Cash and marketable securities held in Trust Account		2,070,086,006
Working capital		3,218,168
Amount deposited in trust account		$ 86,000
Subsequent Event
Maximum borrowing capacity of related party promissory note			$ 1,500,000
IPO
Stock issued during period, shares, new issues	207,000,000	207,000,000
Shares issued, price per share	$ 10
Proceeds from Issuance Initial Public Offering	$ 2,070,000,000
Class of warrant or right, exercise price of warrants or rights		$ 11.50
Transaction Cost Related To Issuance Of Common Stock	109,714,885
Underwriting Fees	36,403,600
Deferred Underwriting Fee Payable Non current	72,450,000
Other Costs Related To Issuance Of Common Stock	$ 861,285
Over-Allotment Option
Stock issued during period, shares, new issues	27,000,000	27,000,000
Shares issued, price per share	$ 10
Private Placement
Number Of warrants issued		42,850,000
Class of warrant or right, exercise price of warrants or rights		$ 1
Proceeds from Issuance of Warrants		$ 42,850,000
Churchill Sponsor LLC [Member]
Business Combination Aggregate Fair Market Value On Assets Held In Trust Percentage	80.00%
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	$ 5,000,001

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Balance Sheet (Details) - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Aug. 03, 2020	Jul. 30, 2020	Apr. 29, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Liabilities	$ 216,178,873	$ 207,885,833	$ 155,872,000
Class A Common Stock Subject to Possible Redemption	1,853,437,770	1,862,600,995	1,914,737,110
Additional Paid-in Capital	68,460,540	59,297,406	7,161,813
Accumulated Deficit	(63,467,875)	(54,304,650)	(2,168,536)
Shareholders' Equity	$ 5,000,006	$ 5,000,006	$ 5,000,005		$ 0
Number of shares subject to redemption	185,343,777	186,248,002	191,473,711
Class A Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A Common Stock	$ 2,166	$ 2,075	$ 1,553
Number of shares subject to redemption	185,343,777			185,343,777
As Previously Reported | Restatement of warrants as derivative liabilities
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Liabilities	$ 73,978,373	72,483,333	72,450,000
Class A Common Stock Subject to Possible Redemption	1,995,638,270	1,998,003,495	1,998,159,110
Additional Paid-in Capital	7,515,926	5,150,724	4,995,112
Accumulated Deficit	(2,521,839)	(156,614)	(1,000)
Shareholders' Equity	$ 5,000,006	$ 5,000,006	$ 5,000,005
Number of shares subject to redemption	199,563,827	199,787,373	199,815,911
As Previously Reported | Restatement of warrants as derivative liabilities | Class A Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A Common Stock	$ 744	$ 721	$ 718
As Adjustments | Restatement of warrants as derivative liabilities
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Liabilities	142,200,500	135,402,500	83,422,000
Class A Common Stock Subject to Possible Redemption	(142,200,500)	(135,402,500)	(83,422,000)
Additional Paid-in Capital	60,944,614	54,146,682	2,166,701
Accumulated Deficit	$ (60,946,036)	$ (54,148,036)	$ (2,167,536)
Number of shares subject to redemption	(14,220,050)	(13,539,371)	(8,342,200)
As Adjustments | Restatement of warrants as derivative liabilities | Class A Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A Common Stock	$ 1,422	$ 1,354	$ 835

RESTATEMENT OF PREVIOUSLY ISS_4

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Statement of Operations (Details) - USD ($)	3 Months Ended	5 Months Ended	8 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Loss	$ (54,303,650)	$ (54,304,650)	$ (63,467,875)
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption	191,473,711	191,473,711	188,268,610
Basic and diluted net income per share, Class A common stock subject to possible redemption	$ 0	$ 0	$ 0
Basic and diluted weighted average shares outstanding, Non-redeemable common stock	59,043,747	54,862,784	62,139,949
Basic and diluted net loss per share, Non-redeemable common stock	$ (0.92)	$ (0.99)	$ (1.02)
As Previously Reported | Restatement of warrants as derivative liabilities
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Loss	$ (155,614)	$ (156,614)	$ (2,521,839)
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption	199,815,911	199,815,911	199,798,408
Basic and diluted net income per share, Class A common stock subject to possible redemption	$ 0	$ 0	$ 0
Basic and diluted weighted average shares outstanding, Non-redeemable common stock	53,784,534	51,169,291	54,384,479
Basic and diluted net loss per share, Non-redeemable common stock	$ 0	$ 0	$ (0.05)
As Adjustments | Restatement of warrants as derivative liabilities
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net Loss	$ (54,148,036)	$ (54,148,036)	$ (60,946,036)
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption	(8,342,200)	(8,342,200)	(11,529,798)
Basic and diluted net income per share, Class A common stock subject to possible redemption	$ 0	$ 0	$ 0
Basic and diluted weighted average shares outstanding, Non-redeemable common stock	5,259,213	3,693,493	7,755,470
Basic and diluted net loss per share, Non-redeemable common stock	$ (0.92)	$ (0.99)	$ (0.97)

RESTATEMENT OF PREVIOUSLY ISS_5

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Statement of Cash Flows (Details) - USD ($)	3 Months Ended	5 Months Ended	8 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss	$ (54,303,650)	$ (54,304,650)	$ (63,467,875)
Loss on warrant liabilities		51,980,500	58,778,500
Transaction costs attributable to Initial Public Offering		2,167,536	2,167,536
Initial classification of Class A common stock subject to possible redemption		1,914,737,110	1,914,737,110
Change in value of Class A common stock subject to possible redemption		(52,136,115)	(61,299,340)
As Previously Reported | Restatement of warrants as derivative liabilities
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss	(155,614)	(156,614)	(2,521,839)
Initial classification of Class A common stock subject to possible redemption		1,998,159,110	1,998,159,110
Change in value of Class A common stock subject to possible redemption		(155,615)	(2,520,840)
As Adjustments | Restatement of warrants as derivative liabilities
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss	$ (54,148,036)	(54,148,036)	(60,946,036)
Loss on warrant liabilities		51,980,500	58,778,500
Transaction costs attributable to Initial Public Offering		2,167,536	2,167,536
Initial classification of Class A common stock subject to possible redemption		(83,422,000)	(83,422,000)
Change in value of Class A common stock subject to possible redemption		$ (51,980,500)	$ (58,778,500)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Mar. 27, 2020	Mar. 26, 2020	Dec. 31, 2020
Interest earned on the Trust Account withdrawn for working capital purposes.			$ 450,000
Unrecognized Tax Benefits			0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued			0
Business interest limitation, percentage	50.00%	30.00%
Cash, FDIC Insured Amount			$ 250,000
If Underwriters Do Not Exercise Overallotment Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			84,250,000

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) per Common Share (Details) - USD ($)	3 Months Ended	5 Months Ended	8 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Numerator: Earnings allocable to Class A common stock subject to possible redemption
Interest income			$ 475,781
Unrealized gain on investments held in Trust Account			4,159
Less: Company's portion available to be withdrawn to pay taxes			(193,315)
Less: Company's portion available to be withdrawn for working capital purposes			$ (286,625)
Denominator: Weighted average Class A common stock subject to possible redemption
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption	191,473,711	191,473,711	188,268,610
Basic and diluted net income per share, Class A common stock subject to possible redemption	$ 0	$ 0	$ 0
Non-Redeemable Common Stock Numerator: Net loss minus net earnings
Net loss	$ (54,303,650)	$ (54,304,650)	$ (63,467,875)
Non-redeemable net loss			$ (63,467,875)
Denominator: Weighted average non-redeemable Class B common stock
Basic and diluted weighted average shares outstanding, Non-redeemable Class B common stock	59,043,747	54,862,784	62,139,949
Basic and diluted net loss per share, Non-redeemable Class B common stock	$ (0.92)	$ (0.99)	$ (1.02)

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - $ / shares	Aug. 03, 2020	Dec. 31, 2020
Exercise price of warrants		$ 11.50
Number of warrants issued		41,400,000
IPO
Number of shares issued	207,000,000	207,000,000
Number of shares in a unit		1
Number of warrants in a unit		0.2
Number of shares issuable per warrant		1
Exercise price of warrants		$ 11.50
Over-Allotment Option
Number of shares issued	27,000,000	27,000,000
Unit price		$ 10
Class A Common Stock | IPO
Number of shares issued		207,000,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details)	8 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Class of warrant or right, exercise price of warrants or rights | $ / shares	$ 11.50
Sale of 42,850,000 private placement warrants | $	$ 42,850,000
Private Placement
Number Of warrants issued | shares	42,850,000
Class of warrant or right, exercise price of warrants or rights | $ / shares	$ 1
Sale of 42,850,000 private placement warrants | $	$ 42,850,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	Aug. 03, 2020	Jul. 30, 2020	Jul. 27, 2020	May 22, 2020	May 13, 2020	Dec. 31, 2020
Issuance of Class B common stock						$ 25,000
Fees incurred for services						250,000
Initial public offering cost					$ 600,000
Repayment of promissory note - related party	$ 550,000					550,000
Debt conversion, original debt, amount						$ 1,500,000
Conversion price						$ 1
Over-Allotment Option
Issuance of Class B common stock (in shares)	27,000,000					27,000,000
Sponsor
Weighted average number of shares, common stock subject to repurchase or cancellation						6,750,000
Equity method investment, ownership percentage						20.00%
Sponsor | Over-Allotment Option
Weighted average number of shares, common stock subject to repurchase or cancellation						6,750,000
Administrative Support Agreement
Management fee expense		$ 50,000
Class A Common Stock
Common Stock, Shares, Issued		21,656,223				21,656,223
Common stock, shares, outstanding		7,436,173				7,436,173
Share price						$ 12
Class B Common Stock
Issuance of Class B common stock (in shares)				21,562,500
Issuance of Class B common stock				$ 25,000
Common stock dividends per share		$ 0.20	$ 0.50
Effected common stock dividend share		1	1
Common Stock, Shares, Issued		51,750,000				51,750,000
Common stock, shares, outstanding		51,750,000				51,750,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)	8 Months Ended
	Dec. 31, 2020USD ($)$ / shares
COMMITMENTS AND CONTINGENCIES
Deferred Underwriting Fees Payable Per Unit | $ / shares	$ 0.35
Deferred Underwriting Fees Payable	$ 72,450,000
Deferred Underwriting Discount Shares	19,982,000
Deferred Underwriting Upfront Payment	3,996,400
Reimbursement of expenses payable	1,000,000
Legal fees	$ 2,152,960

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details)	Dec. 31, 2020$ / sharesshares	Sep. 30, 2020shares	Aug. 03, 2020shares	Jul. 30, 2020USD ($)$ / sharesshares
Preferred Stock, Shares Authorized	1,000,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001
Preferred Stock, Shares Issued	0
Preferred Stock, Shares Outstanding	0
Class A common stock subject to possible redemption	185,343,777	186,248,002	191,473,711
Sponsor
Equity Method Investment, Ownership Percentage	20.00%
Class A Common Stock
Common Stock, Shares Authorized	400,000,000			400,000,000
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001			$ 0.0001
Common shares, votes per share | $				1
Common Stock, Shares, Issued	21,656,223			21,656,223
Common Stock, Shares, Outstanding	7,436,173			7,436,173
Class A common stock subject to possible redemption	185,343,777			185,343,777
Class B Common Stock
Common Stock, Shares Authorized	100,000,000			100,000,000
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001			$ 0.0001
Common shares, votes per share | $				1
Common Stock, Shares, Issued	51,750,000			51,750,000
Common Stock, Shares, Outstanding	51,750,000			51,750,000

WARRANT LIABILITY (Details)

WARRANT LIABILITY (Details) - Public Warrants	8 Months Ended
	Dec. 31, 2020D$ / shares
Class of Warrant or Right [Line Items]
Public Warrants exercisable term after the completion of a business combination	30 days
Public Warrants exercisable term from the closing of the initial public offering	12 months
Class of Warrant or Right Warrants Expiration Period	5 years
Threshold period for filling registration statement after business combination	15 days
Maximum threshold period for registration statement to become effective after business combination	60 days
Class of Warrant or Right Warrants Redemption Price	$ 0.01
Redemption period	30 days
Share Price	$ 18
Threshold trading days for redemption of public warrants | D	20
Minimum threshold written notice period for redemption of public warrants	30 days

INCOME TAX - Net deferred tax a

INCOME TAX - Net deferred tax asset (Details)	Dec. 31, 2020USD ($)
Deferred tax asset
Startup/organizational expenses	$ 596,809
Unrealized gain on marketable securities	(2,900)
Total deferred tax asset	593,909
Valuation Allowance	$ (593,909)

INCOME TAX - Components of Comp

INCOME TAX - Components of Company's income tax provision (Details)	8 Months Ended
	Dec. 31, 2020USD ($)
Federal
Current	$ 81,422
Deferred	(593,909)
Change in valuation allowance	593,909
Income tax provision	$ 81,422

INCOME TAX - Effective Tax Reco

INCOME TAX - Effective Tax Reconciliation (Details)	8 Months Ended
	Dec. 31, 2020
INCOME TAX
Statutory federal income tax rate	21.00%
State taxes, net of federal tax benefit	0.00%
Loss on warrant liability	(19.50%)
Transaction costs incurred in connection with IPO	(0.70%)
Valuation allowance	(0.90%)
Income tax provision	(0.10%)

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details)	Dec. 31, 2020USD ($)
Liabilities:
Warrant Liability	$ 142,200,500
Recurring | Level 1
Assets:
Marketable securities held in Trust Account	2,070,086,006
Public Warrants
Liabilities:
Warrant Liability	62,928,000
Public Warrants | Recurring | Level 1
Liabilities:
Warrant Liability	62,928,000
Private Placement Warrants
Liabilities:
Warrant Liability	79,272,500
Private Placement Warrants | Recurring | Level 3
Liabilities:
Warrant Liability	$ 79,272,500

FAIR VALUE MEASUREMENTS - Signi

FAIR VALUE MEASUREMENTS - Significant inputs (Details)	Dec. 31, 2020Y$ / shares	Jul. 30, 2020Y$ / shares
Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Input	11.50	11.50
Stock price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Input	10.01	9.80
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Input	30	19.8
Probability of completing a Business Combination
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Input	80	80
Term
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Input | Y	5.33	5.33
Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Input	0.50	0.34
Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Input	0	0

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Changes in the fair value of warrant liabilities (Details)	8 Months Ended
	Dec. 31, 2020USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Initial measurement on July 30, 2020	$ 83,422,000
Change in valuation inputs or other assumptions	58,778,500
Fair value as of December 31, 2020	142,200,500
Public Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Initial measurement on July 30, 2020	40,572,000
Change in valuation inputs or other assumptions	22,356,000
Fair value as of December 31, 2020	62,928,000
Private Placement Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Initial measurement on July 30, 2020	42,850,000
Change in valuation inputs or other assumptions	36,422,500
Fair value as of December 31, 2020	$ 79,272,500

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details)	Feb. 22, 2021USD ($)$ / shares	Dec. 31, 2020USD ($)$ / shares	Feb. 20, 2021USD ($)	Jul. 30, 2020$ / shares
Subsequent Event [Line Items]
Values of shares issued		$ 25,000
Amounts borrowed		$ 550,000
Subsequent Event
Subsequent Event [Line Items]
Fee payable to service provider upon the consummation of a Business Combination			$ 6,000,000
Fee payable to service provider upon consummation of the financing			500,000
Threshold maximum out-of-pocket expenses			$ 125,000
Maximum borrowing capacity of related party promissory note	$ 1,500,000
Subsequent Event | Convertible promissory note with Sponsor
Subsequent Event [Line Items]
Maximum borrowing capacity of related party promissory note	1,500,000
Maximum loans convertible into warrants	$ 1,500,000
Price of warrants (in dollars per share) | $ / shares	$ 1
Amounts borrowed	$ 1,500,000
Subsequent Event | Merger Agreement with Merger Sub and Atieva
Subsequent Event [Line Items]
Consideration	$ 11,750,000,000
Number of business days prior to closing date considered for determination of Equity Value	2
Class A Common Stock
Subsequent Event [Line Items]
Par value (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001
Share price | $ / shares		$ 12
Class A Common Stock | Subsequent Event | Common Stock Subscription Agreements | PIPE Investors
Subsequent Event [Line Items]
Values of shares issued	$ 2,500,000,000
Share price | $ / shares	$ 15
Class A Common Stock | Subsequent Event | Merger Agreement with Merger Sub and Atieva
Subsequent Event [Line Items]
Par value (in dollars per share) | $ / shares	0.0001
Merger consideration (in dollars per share) | $ / shares	$ 10